Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoChange DetectedA new page revision number was added (v3.6.6) replacing the previous (v3.6.5). This indicates an internal update to the page version rather than a change to study information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new build of the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check45 days agoChange DetectedThe site template was updated to version v3.6.4, reflecting an internal revision to the page framework. No substantive study information appears to have changed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now lists Revision: v3.6.3, replacing the prior v3.6.0. This indicates a backend or formatting update without changing the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedThe study page now indicates recruitment is closed and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). There is a minor formatting update to the Intervention/Treatment heading and the revision tag at the bottom has been updated from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check88 days agoChange DetectedThe page's revision tag was updated to v3.5.5, signaling a minor metadata update. No study content, eligibility criteria, or results were changed.SummaryDifference0.1%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.